| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 1643 | (+)-HNO hydrochloride |
1643.0001: 1 mg per vial 1643.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
|
|
Precursor for [11C]-(+)-PHNO Precursor for [18F]-(+)-F-PHNO |
||
| Molar Mass: 241.71 | ||
| C12H15NO2 ⋅ HCl | ||
| [858517-21-2] | ||
| Beige solid packaged in dark glass screw cap vials. | ||
| Purity: > 95 % | ||
|
Certificates:
CoA; 1H NMR spectrum |
||
|
Chemical Name: CA index name: 2H-Naphtho[1,2-b]-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-, hydrochloride (1:1), (4aR,10bR) |
||
|
Synonymes: (4aR,10bR)- 3,4,4a,5,6,10b-hexahydro-2H-Naphth[1,2-b]-1,4-oxazin-9-ol, hydrochloride; (+)-3,4,4a,5,6,10b-Hexahydro-2H-naphtho[1,2-β][1,4]oxazin-9-ol hydrochloride; (4aR,10bR)-3,4,4a,5,6,10b-Hexahydro-2H-Naphth[1,2-β]-1,4-oxazin-9-ol, hydrochloride; (+)-HNO [11C]-(+)-PHNO = [11C]-(+)-4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol [18F]-(+)-F-PHNO = [18F]-(+)-4-Fluoropropyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol |
||
|
Literature: 1. Wilson et al. [11C]-(+)-4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a Potential Radiotracer for in Vivo Imaging of the Dopamine D2 High-Affinity State with Positron Emission Tomography. J. Med. Chem. 2005, 48, 4153-4160. |
||
| 2. Boileau et al. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease. Brain, 2009, 132, 1366-1375. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1